Sharing R&D Risk in Healthcare via FDA Hedges
收藏数据链接：
官方服务：
资源简介：
The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We analyze new and simple financial
提供机构：
美国国家经济研究局创建时间：
2017-05-01
